ESIC circular U-16013/141/2022-AYUSH-Part (2) · 16 Feb 2026
Official title
Extension of DG ESIC Ayurvedic Rate Contract No. Ay.-9 (from 17.01.2026 to 16.06.2026) (English)
Official record
Open source pageSummary
Check the official recordThe Director General of ESIC extends the validity of Rate Contract No. Ay.-9 for Ayurvedic drugs. The extension period begins on 17 January 2026 and ends on 16 June 2026. The contract remains valid until the finalization of a new Rate Contract if that occurs before 16 June 2026. ESIC hospitals and medical colleges must confirm the willingness of firms to supply goods under existing terms. Authorities must not order drugs that fail test analysis. Supply orders must go only to first preference holders. Officials must consider previous amendments to the contract when they place new orders.
What you must do
Key dates
Who is affected
Exceptions
File No. U-16013/141/2022-AYUSH-Part (2) Date: 16.02.2026 To, The Deans - All PGIMSR / ESIC Medical College & Hospitals The Medical Superintendent – All ESIC Hospitals The Director (Medical) Delhi/Noida The Director, ESI Scheme –All States Regional Director - All States Subject: Extension of DG ESIC Rate Contract No. Ay. 9 issued vide No. U- 15/13/6/ Ayur.-9/2022-AYUSH, dated 17.11.2023 Madam/Sir, I am hereby directed to inform the approval of Director General ESIC for extension of existing DG ESIC Rate Contract No. Ay.9 w.e.f 17.01.2026 to 16.06.2026 (earlier extended from 17.11.2025 to 16.01.2026) or till the finalization of the new Rate Contract, whichever is earlier subject to the following terms & conditions: 1.Willingness of the firm to supply on the same terms and conditions as approved in rate contract No. Ay.9. 2.No order should be placed in respect of drugs, which have been found "Not of Standard Quality" on test analysis. 3.Supply order should be placed only to first preference holders. 4.Amendments /orders (if any) already issued time to time in r/o items /firms of Rate Contract No. Ay.9 to be taken into consideration while placing the supply orders. The list of L-1 drugs approved under DG ESIC Rate Contract no. Ay.-9 is attached for your information and further necessary action. This is for your kind information and further necessary action. This is issued with approval of the Competent Authority. Yours sincerely,
(Dr. Pawan Kumar) DMC (AYUSH) Copy to:
PPS / PS to DG, FC, MC (Ayush) U-16013/141/2022-AYUSH-Part(2) I/3590791/2026
Account Branch V, ESIC Hqrs Office
Zonal Medical Commissioners (North, South, East, West, North East)
Website Content Manager for uploading on ESIC website
Guard File U-16013/141/2022-AYUSH-Part(2) I/3590791/2026
